Treatment with nintedanib is as effective and safe in patients with other connective tissue diseases (CTDs)-interstitial lung disease (ILD) as in patients with systemic sclerosis-ILD: A multicenter retrospective study
In summary, the use of NTD in combination with immunosuppressive therapies was effective and safe in SSc-ILD patients as well as in other CTDs-ILD patients. Key Points • This multicenter study provides real-world data on the use of nintedanib in patients with connective tissue disease-interstitial lung disease. • Nintedanib treatment is as effective and safe in patients with other connective tissue disease as in patients with systemic sclerosis.
Authors
- Ediz Dalkılıç (ORCID: https://orcid.org/0000-0001-8645-2670)
- Burak Okyar (ORCID: https://orcid.org/0000-0002-9028-9930)
- Salim Mısırcı (ORCID: https://orcid.org/0000-0002-9362-1855)
- Burcu Yağız (ORCID: https://orcid.org/0000-0002-0624-1986)
- Belkıs Nihan Coşkun (ORCID: https://orcid.org/0000-0003-0298-4157)
- Nurhan Atilla (ORCID: https://orcid.org/0000-0003-4127-4924)
- Gözde Yıldırım Çetin (ORCID: https://orcid.org/0000-0001-9680-7535)
- Merih Bırlık (ORCID: https://orcid.org/0000-0001-5118-9307)
- Aylin Dolu Karaca (ORCID: https://orcid.org/0000-0002-5663-0664)
- Yavuz Pehlivan (ORCID: https://orcid.org/0000-0002-7054-5351)
- Ali Ekin (ORCID: https://orcid.org/0000-0003-3692-1293)
- Süleyman Serdar Koca (ORCID: https://orcid.org/0000-0003-4995-430X)
- İ̇smail Sarı (ORCID: https://orcid.org/0000-0001-7737-4180)
- Fatma Başıbüyük (ORCID: https://orcid.org/0000-0002-9564-1139)
Institutions
- Bursa Uludağ Üni̇versi̇tesi̇ (TR)
- Fırat University (TR)
- Dokuz Eylül University (TR)
- Kahramanmaraş Sütçü İmam University (TR)
Publication Details
- Journal
- Clinical Rheumatology
- Published
- 2025-02-07
- DOI
- https://doi.org/10.1007/s10067-025-07323-0
- Citations
- 7
- Primary Topic
- Systemic Sclerosis and Related Diseases
- Type
- article
- Field-Weighted Citation Impact
- 10.30